Le Lézard
Classified in: Health
Subject: CFG

Ministerial Statement - Joint Statement by Ministers Lametti and Hajdu on court ruling to extend the Truchon decision on medical assistance in dying


OTTAWA, ON, Feb. 25, 2021 /CNW/ - The Honourable David Lametti, Minister of Justice and Attorney General of Canada, and the Honourable Patty Hajdu, Minister of Health, today issued the following statement:

"On February 19, 2021, the Attorney General of Canada filed a motion with the Superior Court of Québec requesting a fourth extension of the Truchon decision rendered in September 2019, which would otherwise come into effect after February 26, 2021.

"Today, the Superior Court of Québec has granted this extension until March 26, 2021. Because of this extension, the Criminal Code's medical assistance in dying provisions will remain the same across Canada until March 26, 2021, or until Parliament enacts a new medical assistance in dying law.

"We know Canadians across the country, especially those who are suffering intolerably and would become eligible for MAID under the proposed changes, are anxious to see the proposed amendments come into effect.

"The proposed changes to Canada's MAID law are in the final steps of the legislative process. We remain committed and urge all Parliamentarians to work with us to respond to this important court ruling as quickly as possible."

SOURCE Department of Justice Canada


These press releases may also interest you

at 09:50
Exegenesis Bio, a rapidly growing global genetic medicines company, is pleased to announce the presentation of clinical efficacy and safety data from its EXG001-307 Phase 1/2 clinical trial in Spinal Muscular Atrophy (SMA) Type I at the American...

at 09:47
BioAro, a pioneer in genomic research and technology, is set to officially launch PanOmiQ, a revolutionary software that will redefine the landscape of genomic analysis globally by providing real-time insights into the complexities of the human...

at 09:45
Pleio, Inc. and FountainRx announce their partnership to provide a concierge-level experience to specialty pharmacy patients. The two companies are launching a program to provide patients with human-driven support as they onboard onto their specialty...

at 09:45
JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today released a Virtual Investor "What This Means" segment featuring Moleculin Biotech , a clinical stage pharmaceutical company with a...

at 09:41
Hyundai Bioscience announced on April 25th that, after multiple consultations with global clinical research organizations (CRO), it has decided to conduct clinical trials for its 'niclosamide-based Dengue antiviral' in...

at 09:35
Inocras, a leading AI-driven whole genome testing company, proudly announces the launch of CancerVision and RareVision, its flagship whole genome diagnostics solutions in solid tumor cancer and rare disease, respectively. CancerVision and...



News published on and distributed by: